Cheaper Cancer Drugs in India? Import Duty Waiver Under Consideration
Hope for Affordable Cancer Care: India Considers Import Duty Waiver on Life-Saving Drugs
In a move that could bring much-needed relief to cancer patients, India is considering a significant reduction in the cost of vital cancer medications. The government is exploring the possibility of completely waiving import duties on several blockbuster cancer drugs.
Which Drugs Could Become Cheaper?
The potential import duty waiver applies to some of the most effective cancer treatments currently available. This includes:
- Pembrolizumab (Keytruda): A groundbreaking immunotherapy drug used in the fight against various cancers, including lung cancer.
- Osimertinib (Tagrisso): A targeted therapy specifically for certain types of lung cancer.
- Trastuzumab Deruxtecan (Enhertu): A revolutionary treatment for advanced breast cancer.
Impact on Patients
This potential waiver could drastically reduce the financial burden on patients battling these devastating diseases. The high cost of these medications often makes them inaccessible to many, and this move offers a glimmer of hope for more affordable cancer care in India. The government’s consideration of this waiver underscores a commitment to improving access to life-saving treatments.